secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001731122-22-002139
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Mark Dybul takes $300K base salary cut; Francois Binette named COO
----------------------------------------------------------------------

- CEO Dybul base salary reduced from $850K to $550K/year effective Jan 1, 2023; variable comp cap raised to $800K/year.
- Dybul awarded $100K cash bonus for 2022 performance, payable by March 15, 2023.
- Francois Binette appointed COO effective Nov 1, 2022; base salary increased to $420K/year plus 40,000 stock options.
- CFO Luisa Puche base salary increased to $350K/year; granted 80,000 stock options for 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222002139/0001731122-22-002139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222002139/e4298_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-22-002139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer